Geriatric Medicines Market by Indication Types (Arthritis, Cancer, Cardiovascular, Neurological, Osteoporosis, Respiratory), and Therapeutic Areas (Analgesics, Anticoagulants, Antidiabetic, Antihypertensive, Antipsychotics, Proton Pump Inhibitors, Statins) and Forecast 2017-2021

Geriatric Medicines Market by Indication Types (Arthritis, Cancer, Cardiovascular, Neurological, Osteoporosis, Respiratory), and Therapeutic Areas (Analgesics, Anticoagulants, Antidiabetic, Antihypertensive, Antipsychotics, Proton Pump Inhibitors, Statins) and Forecast 2017-2021

Geriatric medicine is a subspecialty of internal medicine or family medicine that deals with the complex medical and psychosocial problems of older adults, and it is rapidly evolving into both a hospital-based specialty and a specialty concerned with community care. Geriatric medicine is a branch of medicine concerned with clinical, remedial, preventive, and social aspects of disorders usually among people aged 65 years and above. The geriatric population requires more palliative care and support as compared with younger adults due to reduced immunity of the geriatrics. Increasing chronic diseases among geriatrics and favorable government initiative toward geriatric care is driving demand for geriatric medicines worldwide.

The global geriatric medicines market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the indication types (arthritis, cancer, cardiovascular, neurological, osteoporosis, respiratory, etc.), and therapeutic areas (analgesics, anticoagulants, antidiabetic, antihypertensive, antipsychotics, proton pump inhibitors, statins, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).

The global geriatric medicines market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global geriatric medicines market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global geriatric medicines market and included in this report are Abbott Laboratories, Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Eli Lilly and Company, Novartis AG, Pfizer, Inc., Merck & Company Inc., GlaxoSmithKline plc and Sanofi S.A.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Geriatric Medicines Market

1. Indication Type
1.1. Arthritis
1.2. Cancer
1.3. Cardiovascular
1.4. Neurological
1.5. Osteoporosis
1.6. Respiratory
1.7. Others

2. Therapeutic Area
2.1. Analgesics
2.2. Anticoagulants
2.3. Antidiabetic
2.4. Antihypertensive
2.5. Antipsychotics
2.6. Proton Pump Inhibitors
2.7. Statins
2.8. Others

3. Company Profiles
3.1. Abbott Laboratories, Inc.
3.2. AstraZeneca plc.
3.3. Boehringer Ingelheim GmbH
3.4. Bristol-Myers Squibb Company
3.5. Eli Lilly and Company
3.6. GlaxoSmithKline Plc.
3.7. Merck & Company Inc.
3.8. Novartis AG
3.9. Pfizer, Inc.
3.10. Sanofi S.A

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*